Free Trial

Puma Biotechnology (PBYI) Short Interest Ratio & Short Volume

Puma Biotechnology logo
$3.45 -0.02 (-0.58%)
Closing price 04:00 PM Eastern
Extended Trading
$3.40 -0.05 (-1.33%)
As of 05:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Puma Biotechnology Short Interest Data

Puma Biotechnology (PBYI) has a short interest of 2.63 million shares, representing 7.05% of the float (the number of shares available for trading by the public). This marks a -1.87% decrease in short interest from the previous month. The short interest ratio (days to cover) is 7.4, indicating that it would take 7.4 days of the average trading volume of 413,438 shares to cover all short positions.

Current Short Interest
2,630,000 shares
Previous Short Interest
2,680,000 shares
Change Vs. Previous Month
-1.87%
Dollar Volume Sold Short
$9.02 million
Short Interest Ratio
7.4 Days to Cover
Last Record Date
June 30, 2025
Outstanding Shares
49,630,000 shares
Float Size
37,280,000 shares
Short Percent of Float
7.05%
Today's Trading Volume
302,655 shares
Average Trading Volume
413,438 shares
Today's Volume Vs. Average
73%
Short Selling Puma Biotechnology?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Puma Biotechnology and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

PBYI Short Interest Over Time

PBYI Days to Cover Over Time

PBYI Percentage of Float Shorted Over Time

Puma Biotechnology Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/20252,630,000 shares $9.02 million -1.9%7.1%7.4 $3.43
6/15/20252,680,000 shares $8.98 million -3.6%7.2%7.8 $3.35
5/31/20252,780,000 shares $9.26 million -3.1%7.4%7.5 $3.33
5/15/20252,870,000 shares $9.41 million -2.1%7.7%7.2 $3.28
4/30/20252,930,000 shares $9.32 million +2.1%7.5%7.9 $3.18
4/15/20252,870,000 shares $8.50 million -0.4%7.4%7.7 $2.96
3/31/20252,880,000 shares $8.52 million +3.2%7.4%5.9 $2.96
3/15/20252,790,000 shares $9.26 million -11.7%7.2%5.2 $3.32
2/28/20253,160,000 shares $11.31 million +2.9%8.1%5.8 $3.58
2/15/20253,070,000 shares $8.78 million +3.0%8.0%6.2 $2.86
1/31/20252,980,000 shares $8.61 million -2.9%8.5%5 $2.89
1/15/20253,070,000 shares $9.42 million +2.0%8.8%5.3 $3.07
12/31/20243,010,000 shares $9.18 million +3.4%8.6%5.8 $3.05
12/15/20242,910,000 shares $8.38 million +3.6%8.4%7.2 $2.88
11/30/20242,810,000 shares $9.53 million -5.7%8.1%7.2 $3.39
11/15/20242,980,000 shares $7.21 million -6.6%8.6%8.2 $2.42
10/31/20243,190,000 shares $9.09 million -11.9%9.1%9.2 $2.85
10/15/20243,620,000 shares $10.32 million +6.2%10.3%11.2 $2.85
9/30/20243,410,000 shares $8.70 million -5.8%9.7%9.8 $2.55
9/15/20243,620,000 shares $9.16 million +4.0%10.3%7.6 $2.53
8/31/20243,480,000 shares $8.70 million -13.0%10.0%7.3 $2.50
8/15/20244,000,000 shares $10.60 million +4.7%11.5%8.6 $2.65
7/31/20243,820,000 shares $13.69 million +0.5%10.8%8 $3.59
7/15/20243,800,000 shares $13.91 million +29.7%10.9%8.2 $3.66
6/30/20242,930,000 shares $9.55 million +8.5%8.4%6.5 $3.26
6/15/20242,700,000 shares $8.40 million +7.6%7.6%7.4 $3.11
5/31/20242,510,000 shares $9.66 million -17.4%7.1%6.1 $3.85
5/15/20243,040,000 shares $14.14 million -2.3%8.6%5.8 $4.65
4/30/20243,110,000 shares $15.77 million -6.6%9.0%5.4 $5.07
4/15/20243,330,000 shares $17.82 million +1.2%9.6%5.9 $5.35
3/31/20243,290,000 shares $17.44 million -1.2%9.5%5.4 $5.30
3/15/20243,330,000 shares $16.65 million -18.6%9.0%5.5 $5.00
2/29/20244,090,000 shares $25.44 million +13.9%11.0%7.8 $6.22
2/15/20243,590,000 shares $25.09 million +11.8%9.8%7.9 $6.99
1/31/20243,210,000 shares $15.09 million +6.3%8.7%9 $4.70
1/15/20243,020,000 shares $14.95 million +4.1%8.1%9.4 $4.95
12/31/20232,900,000 shares $12.56 million +5.1%7.8%11.1 $4.33
12/15/20232,760,000 shares $10.82 million +35.3%7.4%12.4 $3.92
11/30/20232,040,000 shares $7.96 million +8.5%5.5%10.1 $3.90
11/15/20231,880,000 shares $7.14 million +9.3%5.1%11.1 $3.80
Bitcoin Beats Gold — But This Coin Could Beat Them Both (Ad)

Bitcoin just hit a record high—but it’s not the top crypto play right now. Crypto analyst Juan Villaverde, who called Bitcoin’s breakout to $100K nearly to the day, says a lesser-known coin could be even bigger. It’s faster, cheaper, and backed by Google, Visa, and top VCs with over $200 million already invested.

Get the name of this “third pillar” crypto in Juan’s free report →
10/31/20231,720,000 shares $4.23 million -1.2%4.6%12 $2.46
10/15/20231,740,000 shares $4.11 million -0.6%4.7%13.5 $2.36
9/30/20231,750,000 shares $4.60 million +1.2%4.7%12.6 $2.63
9/15/20231,730,000 shares $5.29 million +3.6%4.7%10.4 $3.06
8/31/20231,670,000 shares $6.06 million +2.5%4.5%9.3 $3.63
8/15/20231,630,000 shares $5.85 million +0.6%4.1%8 $3.59
7/31/20231,620,000 shares $5.86 million -2.4%4.1%7.6 $3.62
7/15/20231,660,000 shares $5.53 million +3.8%4.3%7.8 $3.33
6/30/20231,600,000 shares $5.65 million +11.1%4.1%7.2 $3.53
6/15/20231,440,000 shares $5.11 million +5.9%3.7%5.9 $3.55
5/31/20231,360,000 shares $4.56 million No Change3.4%4.8 $3.35
5/15/20231,360,000 shares $4.00 million -1.5%3.4%4.5 $2.94
4/30/20231,380,000 shares $3.70 million +7.0%3.6%4.5 $2.68
4/15/20231,290,000 shares $3.90 million No Change3.3%4.1 $3.02
3/31/20231,290,000 shares $3.99 million +8.4%3.3%3.9 $3.09
3/15/20231,190,000 shares $2.88 million +3.5%3.1%3.4 $2.42
2/28/20231,150,000 shares $4.44 million +2.7%3.0%3.2 $3.86
2/15/20231,120,000 shares $4.76 million +6.7%3.0%3.1 $4.25
1/31/20231,050,000 shares $4.52 million +12.2%2.8%2.5 $4.30
1/15/2023935,800 shares $4.51 million +6.3%2.5%2.4 $4.82
12/30/2022880,500 shares $3.72 million -38.0%2.3%2.4 $4.23
12/15/20221,420,000 shares $6.97 million -5.3%3.7%4.4 $4.91
11/30/20221,500,000 shares $6.78 million +0.7%3.9%5.7 $4.52
11/15/20221,490,000 shares $5.07 million -2.0%3.9%6.4 $3.40
10/31/20221,520,000 shares $3.31 million No Change3.9%8.5 $2.18
10/15/20221,520,000 shares $3.39 million -5.0%3.9%8.2 $2.23
9/30/20221,600,000 shares $3.79 million -9.6%4.2%7.7 $2.37
9/15/20221,770,000 shares $4.53 million -2.2%4.6%5.8 $2.56
8/31/20221,810,000 shares $4.85 million -1.1%4.7%5.1 $2.68
8/15/20221,830,000 shares $6.31 million +2.2%4.7%4.6 $3.45
7/31/20221,790,000 shares $5.24 million -3.8%4.7%4 $2.93
7/15/20221,860,000 shares $5.86 million -7.5%4.9%4.1 $3.15
6/30/20222,010,000 shares $5.73 million -41.7%5.3%4.4 $2.85
6/15/20223,450,000 shares $10.52 million -1.2%9.1%7.1 $3.05
5/31/20223,490,000 shares $6.77 million +4.8%9.3%8.3 $1.94
5/15/20223,330,000 shares $6.09 million +4.7%8.9%7.4 $1.83
4/30/20223,180,000 shares $7.50 million +2.9%9.2%7.4 $2.36
4/15/20223,090,000 shares $8.74 million -1.6%9.0%7.1 $2.83
3/31/20223,140,000 shares $9.04 million +10.6%9.1%5.7 $2.88
3/15/20222,840,000 shares $7.72 million +21.4%8.2%5.2 $2.72
2/28/20222,340,000 shares $5.38 million +1.7%6.4%3.9 $2.30
2/15/20222,300,000 shares $5.31 million -6.5%6.4%3.7 $2.31
1/31/20222,460,000 shares $6.05 million -4.3%6.8%3.4 $2.46
1/15/20222,570,000 shares $7.14 million -13.5%7.1%3.2 $2.78
12/31/20212,970,000 shares $9.03 million +6.5%8.3%4.3 $3.04
12/15/20212,790,000 shares $8.40 million -10.0%8.0%4 $3.01
11/30/20213,100,000 shares $9.61 million +22.5%8.9%4.8 $3.10
11/15/20212,530,000 shares $9.31 million +4.1%7.2%4.4 $3.68
10/29/20212,430,000 shares $12.39 million -2.8%7.0%4.8 $5.10
10/15/20212,500,000 shares $15.13 million -7.8%7.2%5.8 $6.05
Bitcoin Beats Gold — But This Coin Could Beat Them Both (Ad)

Bitcoin just hit a record high—but it’s not the top crypto play right now. Crypto analyst Juan Villaverde, who called Bitcoin’s breakout to $100K nearly to the day, says a lesser-known coin could be even bigger. It’s faster, cheaper, and backed by Google, Visa, and top VCs with over $200 million already invested.

Get the name of this “third pillar” crypto in Juan’s free report →
9/30/20212,710,000 shares $19.00 million -5.2%7.8%6.7 $7.01
9/15/20212,860,000 shares $19.91 million -0.4%8.2%6.8 $6.96
8/31/20212,870,000 shares $21.73 million -2.4%8.2%6.8 $7.57
8/13/20212,940,000 shares $21.34 million -4.6%8.4%7.1 $7.26
7/30/20213,080,000 shares $23.16 million +6.6%8.9%7.8 $7.52
7/15/20212,890,000 shares $23.67 million +7.0%8.5%8.6 $8.19
6/30/20212,700,000 shares $24.79 million -28.4%7.9%7.8 $9.18
6/15/20213,770,000 shares $39.89 million -2.3%11.0%12.4 $10.58
5/28/20213,860,000 shares $40.72 million -6.1%11.3%13.9 $10.55
5/14/20214,110,000 shares $39.83 million -0.2%12.0%13.6 $9.69
4/30/20214,120,000 shares $40.99 million -10.4%12.1%12.5 $9.95
4/15/20214,600,000 shares $46.87 million -5.7%13.6%12.5 $10.19
3/31/20214,880,000 shares $45.77 million -0.2%14.5%12.9 $9.38
3/15/20214,890,000 shares $55.21 million +0.2%14.5%11.8 $11.29
2/26/20214,880,000 shares $51.48 million +3.6%14.5%10.2 $10.55
2/12/20214,710,000 shares $58.88 million -4.3%14.0%9.1 $12.50
1/29/20214,920,000 shares $57.96 million +0.8%14.6%9.2 $11.78
1/15/20214,880,000 shares $53.68 million -27.0%14.5%8.9 $11.00
12/31/20206,680,000 shares $69.41 million -14.5%19.8%11.8 $10.39
12/15/20207,810,000 shares $85.13 million +0.9%23.2%13.2 $10.90
11/30/20207,740,000 shares $90.79 million -4.2%23.0%13.2 $11.73
11/15/20208,080,000 shares $72.15 million +1.0%24.0%14 $8.93
10/30/20208,000,000 shares $72.80 million +2.2%24.3%13.6 $9.10
10/15/20207,830,000 shares $76.11 million +7.7%23.8%11.1 $9.72
9/30/20207,270,000 shares $73.35 million -1.5%N/A9.9 $10.09
9/15/20207,380,000 shares $73.73 million -0.9%22.5%9.2 $9.99
8/31/20207,450,000 shares $76.66 million +1.5%22.7%8.3 $10.29
8/14/20207,340,000 shares $72.15 million +3.8%22.4%7.6 $9.83
7/31/20207,070,000 shares $72.89 million +2.5%21.2%6.7 $10.31

PBYI Short Interest - Frequently Asked Questions

What is Puma Biotechnology's current short interest?

Short interest is the volume of Puma Biotechnology shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 2,630,000 shares of PBYI short. 7.05% of Puma Biotechnology's shares are currently sold short. Learn More on Puma Biotechnology's current short interest.

What is a good short interest ratio for Puma Biotechnology?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PBYI shares currently have a short interest ratio of 7.0. Learn More on Puma Biotechnology's short interest ratio.

Which institutional investors are shorting Puma Biotechnology?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Puma Biotechnology: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Puma Biotechnology?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.05% of Puma Biotechnology's floating shares are currently sold short.

Is Puma Biotechnology's short interest increasing or decreasing?

Puma Biotechnology saw a drop in short interest in the month of June. As of June 30th, there was short interest totaling 2,630,000 shares, a drop of 1.9% from the previous total of 2,680,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Puma Biotechnology's float size?

Puma Biotechnology currently has issued a total of 49,630,000 shares. Some of Puma Biotechnology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Puma Biotechnology currently has a public float of 37,280,000 shares.

How does Puma Biotechnology's short interest compare to its competitors?

7.05% of Puma Biotechnology's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Puma Biotechnology: ADMA Biologics Inc (7.05%), CytomX Therapeutics, Inc. (29.73%), Entrada Therapeutics, Inc. (5.60%), Maravai LifeSciences Holdings, Inc. (13.29%), Iovance Biotherapeutics, Inc. (35.65%), Urogen Pharma (42.26%), Tilray Brands, Inc. (20.64%), Tango Therapeutics, Inc. (35.96%), Stoke Therapeutics, Inc. (23.34%), Prime Medicine, Inc. (39.00%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks.

What does it mean to sell short Puma Biotechnology stock?

Short selling PBYI is an investing strategy that aims to generate trading profit from Puma Biotechnology as its price is falling. PBYI shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Puma Biotechnology?

A short squeeze for Puma Biotechnology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PBYI, which in turn drives the price of the stock up even further.

How often is Puma Biotechnology's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PBYI, twice per month. The most recent reporting period available is June, 30 2025.




This page (NASDAQ:PBYI) was last updated on 7/23/2025 by MarketBeat.com Staff
From Our Partners